Evidence map›Paper›PMID 37131872›Full record

ArticleArXiv2023

CancerGPT: Few-shot Drug Pair Synergy Prediction using Large Pre-trained Language Models.

Tianhao Li, Sandesh Shetty, Advaith Kamath, Ajay Jaiswal, Xiaoqian Jiang, Ying Ding, Yejin Kim

Abstract readPreprint
In one paragraph

Article in ArXiv, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Computational Approaches: A New Frontier in Cancer Research.Combinatorial chemistry & high throughput screening · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Tianhao LiSchool of Information, University of Texas at Austin, Austin, Texas, USA.
Sandesh ShettyCollege of Information and Computer Sciences, University of Massachusetts Amherst, Amherst, MA, USA.
Advaith KamathDepartment of Chemical Engineering, University of Texas at Austin, Austin, TX, USA.
Ajay JaiswalSchool of Information, University of Texas at Austin, Austin, TX, USA.
Xiaoqian JiangSchool of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA.
Ying DingSchool of Information, University of Texas at Austin, Austin, TX, USA.
Yejin KimSchool of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA.

Funding

Open Health Natural Language Processing CollaboratoryU01TR002062 · NCATS · MAYO CLINIC ROCHESTER · PI JIANG, XIAOQIAN, LIU, HONGFANG · 2017 to 2021
$7.6M
Finding Combinatorial Drug Repositioning Therapy For Alzheimer'S Disease And Related DementiasR01AG066749 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI JIANG, XIAOQIAN, ZHENG, WENJIN JIM · 2020 to 2024
$4.4M
Decentralized differentially-private methods for dynamic data release and analysisR01LM013712 · NLM · YALE UNIVERSITY · PI JIANG, XIAOQIAN, OHNO-MACHADO, LUCILA · 2022 to 2025
$2.5M
NCATS NIH HHS U01 TR002062NIA NIH HHS R01 AG066749NLM NIH HHS R01 LM013712
6 · The paper itself

Abstract

Large pre-trained language models (LLMs) have been shown to have significant potential in few-shot learning across various fields, even with minimal training data. However, their ability to generalize to unseen tasks in more complex fields, such as biology, has yet to be fully evaluated. LLMs can offer a promising alternative approach for biological inference, particularly in cases where structured data and sample size are limited, by extracting prior knowledge from text corpora. Our proposed few-shot learning approach uses LLMs to predict the synergy of drug pairs in rare tissues that lack structured data and features. Our experiments, which involved seven rare tissues from different cancer types, demonstrated that the LLM-based prediction model achieved significant accuracy with very few or zero samples. Our proposed model, the CancerGPT (with ~ 124M parameters), was even comparable to the larger fine-tuned GPT-3 model (with ~ 175B parameters). Our research is the first to tackle drug pair synergy prediction in rare tissues with limited data. We are also the first to utilize an LLM-based prediction model for biological reaction prediction tasks.

Identifiers

PMID37131872
PMCPMC10153348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.